This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.A prospective, single-center, single-arm, open-label trial assessing the safety and efficacy of DSG on post-transplant islet function in subjects with long-standing type 1 diabetes that is refractory to intensive insulin therapy.
Showing the most recent 10 out of 724 publications